# Notice of Intent To Grant Exclusive Patent License; Acambis, Inc.
**AGENCY:**
Department of the Navy, DOD.
**ACTION:**
Notice.
**SUMMARY:**
The Department of the Navy hereby gives notice of its intent to grant to Acambis, Inc., a revocable, nonassignable, exclusive license to practice worldwide the Government-owned inventions described in U.S. Patent application Serial No. 09/439,311, entitled “A Recombinant Polypeptide for Use in the Manufacture of Vaccines Against Campylobacter Induced Diarrhea and to Reduce Colonization” filed November 14, 1998, and its PCT serial number US99/27195 in the field of vaccines against Campylobacter associated disease.
**DATES:**
Anyone wishing to object to the grant of this license has fifteen (15) days from the date of this notice to file written objections along with supporting evidence, if any.
**ADDRESSES:**
Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500.
**FOR FURTHER INFORMATION CONTACT:**
Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500, telephone (301) 319-7428.
Dated: October 15, 2001.
T.J. Welsh,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.